Table of Contents

1 Industry Overview

• 1.1 Amifostine Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Amifostine
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Amifostine Market by Type

• 3.1 By Type
  • 3.1.1 400mg/Dose
  • 3.1.2 500mg/Dose
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Amifostine Clinigen Group (Company Profile, Sales Data etc.)

• 4.2 Sun Pharmaceutical (Company Profile, Sales Data etc.)
• 4.3 Taj Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.4 Merro Pharmaceutical (Company Profile, Sales Data etc.)
• 4.5 Luye Pharma (Company Profile, Sales Data etc.)
• 4.6 Mingren Pharma (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Ovarian Cancer Adjuvant Therapy
  • 6.1.2 Demand in Head and Neck Cancer Adjuvant Therapy
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Amifostine

Table Application Segment of Amifostine

Table Global Amifostine Market 2013-2024, by Application, in USD Million

Table Major Company List of 400mg/Dose

Table Major Company List of 500mg/Dose

Table Global Amifostine Market 2013-2018, by Type, in USD Million

Table Global Amifostine Market 2013-2018, by Type, in Volume

Table Global Amifostine Market Forecast 2019-2024, by Type, in USD Million

Table Global Amifostine Market Forecast 2019-2024, by Type, in Volume

Table Clinigen Group Overview List

Table Amifostine Business Operation of Clinigen Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sun Pharmaceutical Overview List

Table Amifostine Business Operation of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Taj Pharmaceuticals Overview List

Table Amifostine Business Operation of Taj Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merro Pharmaceutical Overview List

Table Amifostine Business Operation of Merro Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Luye Pharma Overview List

Table Amifostine Business Operation of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mingren Pharma Overview List

Table Amifostine Business Operation of Mingren Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Amifostine Sales Revenue 2013-2018, by Company, in USD Million

Table Global Amifostine Sales Revenue Share, by Company, in USD Million

Table Global Amifostine Sales Volume 2013-2018, by Company, in Volume

Table Global Amifostine Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Amifostine Demand Forecast 2019-2024, by Application, in USD Million

Table Amifostine Demand Forecast 2019-2024, by Application, in Volume

Table Amifostine Production 2013-2018, by Region, in USD Million

Table Amifostine Production 2013-2018, by Region, in Volume

Table Global Amifostine Market 2013-2018, by Region, in USD Million

Table Global Amifostine Market Share 2013-2018, by Region, in USD Million

Table Global Amifostine Market 2013-2018, by Region, in Volume

Table Global Amifostine Market Share 2013-2018, by Region, in Volume

Table North America Amifostine Market Size 2013-2018, by Country, in USD Million

Table North America Amifostine Market Size 2013-2018, by Country, in Volume

Table Europe Amifostine Market Size 2013-2018, by Country, in USD Million

Table Europe Amifostine Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Amifostine Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Amifostine Market Size 2013-2018, by Country, in Volume

Table South America Amifostine Market Size 2013-2018, by Country, in USD Million

Table South America Amifostine Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Amifostine Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Amifostine Market Size 2013-2018, by Country, in Volume

Table Amifostine Market Forecast 2019-2024, by Region, in USD Million

Table Amifostine Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Amifostine Market Growth 2013-2018, by Type, in USD Million

Figure Global Amifostine Market Growth 2013-2018, by Type, in Volume

Figure North America Amifostine Market Concentration, in 2018

Figure Europe Amifostine Market Market Concentration, in 2018

Figure Asia-Pacific Amifostine MMarket Concentration, in 2018

Figure South America Amifostine Market Concentration, in 2018

Figure Middle East & Africa Amifostine Market Concentration, in 2018

Figure Amifostine Demand in Ovarian Cancer Adjuvant Therapy, 2013-2018, in USD Million

Figure Amifostine Demand in Ovarian Cancer Adjuvant Therapy, 2013-2018, in Volume

Figure Amifostine Demand in Head and Neck Cancer Adjuvant Therapy, 2013-2018, in USD Million

Figure Amifostine Demand in Head and Neck Cancer Adjuvant Therapy, 2013-2018, in Volume

Figure Amifostine Demand in Others, 2013-2018, in USD Million

Figure Amifostine Demand in Others, 2013-2018, in Volume

Figure North America Amifostine Market Size and Growth 2013-2018, in USD Million

Figure North America Amifostine Market Size and Growth 2013-2018, in Volume

Figure Europe Amifostine Market Size and Growth 2013-2018, in USD Million

Figure Europe Amifostine Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Amifostine Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Amifostine Market Size and Growth 2013-2018, in Volume

Figure South America Amifostine Market Size and Growth 2013-2018, in USD Million

Figure South America Amifostine Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Amifostine Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Amifostine Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Snapshot
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.
The global Amifostine market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Amifostine by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
400mg/Dose
500mg/Dose
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Clinigen Group
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Ovarian Cancer Adjuvant Therapy
Head and Neck Cancer Adjuvant Therapy
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)